MCID: BRS007
MIFTS: 45

Breast Malignant Phyllodes Tumor

Categories: Cancer diseases, Rare diseases, Reproductive diseases

Aliases & Classifications for Breast Malignant Phyllodes Tumor

MalaCards integrated aliases for Breast Malignant Phyllodes Tumor:

Name: Breast Malignant Phyllodes Tumor 12 15
Cystosarcoma Phyllodes of the Breast 52 58
Malignant Phyllodes Tumor of Breast 12 71
Malignant Cystosarcoma Phyllodes 12 71
Phyllodes Tumor of the Breast 52 58
Phyllodes Breast Tumor 12 52
Malignant Mammary Phyllodes Tumor 12
Malignant Breast Phyllodes Tumor 17
Malignant Phyllodes Neoplasm 12
Phyllodes Tumor, Malignant 12
Malignant Phyllodes Tumor 12
Phyllodes Breast Neoplasm 12
Cystosarcoma Phyllodes 52
Breast Phyllodes Tumor 71
Phylloides Tumor 52
Phyllodes Tumor 71

Characteristics:

Orphanet epidemiological data:

58
phyllodes tumor of the breast
Age of onset: Adult;

Classifications:

Orphanet: 58  
Rare gynaecological and obstetric diseases


External Ids:

Disease Ontology 12 DOID:3016
MeSH 43 D003557
SNOMED-CT 67 87913009
MESH via Orphanet 44 D003557
ICD10 via Orphanet 33 D48.6
UMLS via Orphanet 72 C0010701
Orphanet 58 ORPHA180261
UMLS 71 C0010701 C0238031 C0346154 more

Summaries for Breast Malignant Phyllodes Tumor

NIH Rare Diseases : 52 Phyllodes tumors of the breast are rare tumors that start in the connective (stromal) tissue of the breast. They get their name from the leaf-like pattern in which they grow (phyllodes means leaf-like in Greek). They are most common in women in their 30s and 40s, although women of any age can be affected. These tumors, which are usually painless, tend to grow quickly, but rarely spread outside of the breast. Most phyllodes tumors are benign. About 1 in 10 are cancerous. The underlying cause of these tumors in unknown. Surgery is the main treatment. Because the tumors can reoccur if they are not removed with enough surrounding tissue, the tumor and at least 1 cm of tissue should be removed. Cancerous phyllodes tumors are often treated with mastectomy. Close follow-up with frequent breast examinations are recommended after surgery.

MalaCards based summary : Breast Malignant Phyllodes Tumor, also known as cystosarcoma phyllodes of the breast, is related to li-fraumeni syndrome and scirrhous adenocarcinoma. An important gene associated with Breast Malignant Phyllodes Tumor is SERPINA3 (Serpin Family A Member 3), and among its related pathways/superpathways are MAPK signaling pathway and Pathways in cancer. The drugs Fluorouracil and Belinostat have been mentioned in the context of this disorder. Affiliated tissues include breast, prostate and lung, and related phenotypes are cellular and integument

Disease Ontology : 12 A breast cancer that is characterized by a prominent infiltrative border, unequivocal sarcomatous areas, and stromal overgrowth and arises from the stroma, lined by an epithelial and myoepithelial bilayer, forming a leaflike structure. They tend to grow rapidly and present in middle-aged women (40s-50s).

Related Diseases for Breast Malignant Phyllodes Tumor

Diseases in the Benign Breast Phyllodes Tumor family:

Breast Malignant Phyllodes Tumor

Diseases related to Breast Malignant Phyllodes Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 507, show less)
# Related Disease Score Top Affiliating Genes
1 li-fraumeni syndrome 31.8 TP53 ESR1 ERBB2 EGFR
2 scirrhous adenocarcinoma 30.9 PGR ERBB2
3 gynecomastia 30.9 PGR ESR1 ERBB2
4 soft tissue sarcoma 30.8 TP53 EGFR
5 benign mesothelioma 30.6 KRT5 CD34
6 leiomyoma, uterine 30.5 PGR MED12 ESR1
7 malignant mesenchymoma 30.5 SERPINA3 CD34
8 benign breast phyllodes tumor 30.4 PGR MME MED12 KIT
9 bilateral breast cancer 30.3 PGR ESR1 ERBB2
10 mesenchymoma 30.2 SERPINA3 KIT CD34
11 spindle cell carcinoma 30.2 PGR KRT5 ESR1 CD34
12 hypertrophy of breast 30.2 TP53 PGR ESR1 ERBB2
13 female breast cancer 30.2 TP53 PGR ESR1 ERBB2
14 angiosarcoma 30.0 TP53 KIT CD34
15 histiocytoma 30.0 TP53 SERPINA3 KIT CD34
16 adenocarcinoma 30.0 TP53 KIT ERBB2 EGFR
17 embryonal sarcoma 30.0 TP53 SERPINA3 KIT
18 neurilemmoma 29.9 SERPINA3 KIT CD34
19 mammary paget's disease 29.9 PGR ESR1 ERBB2 EGFR
20 intraductal papilloma 29.8 PGR KRT5 ESR1 ERBB2
21 prostatic hypertrophy 29.8 SERPINA3 PGR ESR1 EGFR
22 inflammatory breast carcinoma 29.7 PGR ESR1 ERBB2 EGFR
23 breast fibroadenoma 29.7 TP53 SERPINA3 PGR MME MED12 ESR1
24 lobular neoplasia 29.7 TP53 PGR KRT5 ESR1 ERBB2
25 tubular adenocarcinoma 29.7 PGR MME ESR1 ERBB2 EGFR
26 papilloma 29.5 TP53 KRT5 ESR1 EGFR
27 leiomyosarcoma 29.5 TP53 SERPINA3 PGR MED12 KIT ESR1
28 breast disease 29.4 TP53 SERPINA3 PGR KRT5 ESR1 ERBB2
29 microglandular adenosis 29.3 TP53 PGR ESR1 ERBB2 EGFR
30 in situ carcinoma 29.3 TP53 PGR KRT5 ESR1 ERBB2 EGFR
31 mesenchymal cell neoplasm 29.2 TP53 SERPINA3 MME KIT CD34
32 leiomyoma 29.1 PGR MME MED12 KIT ESR1 CD34
33 cribriform carcinoma 29.1 PGR KRT5 KIT ESR1 ERBB2
34 gastrointestinal stromal tumor 29.0 TP53 KIT ERBB2 EGFR CD34
35 breast adenocarcinoma 29.0 TP53 SERPINA3 PGR MED12 ESR1 ERBB2
36 breast sarcoma 28.8 TP53 PGR MME ESR1 ERBB2 CD34
37 carcinosarcoma 28.7 TP53 PGR MME KIT ERBB2 EGFR
38 adenosarcoma 28.6 TP53 SERPINA3 PGR MME KIT ESR1
39 ductal carcinoma in situ 28.5 TP53 PGR MME KRT5 ESR1 ERBB2
40 benign prostate phyllodes tumor 11.5
41 li-fraumeni syndrome 2 11.4
42 rare tumor 10.7
43 sarcoma 10.6
44 spindle cell sarcoma 10.6
45 liposarcoma 10.5
46 rare breast tumor 10.5
47 fibrosarcoma 10.5
48 adenoma 10.5
49 congenital epulis 10.5 SERPINA3 PGR
50 epulis 10.5 SERPINA3 PGR
51 diffuse peritoneal leiomyomatosis 10.5 PGR MED12
52 peritoneal benign neoplasm 10.5 PGR MED12
53 non-proliferative fibrocystic change of the breast 10.5 SERPINA3 ERBB2
54 bartholin's gland adenoid cystic carcinoma 10.4 PGR ESR1
55 chronic tympanitis 10.4 PGR ESR1
56 granulomatous endometritis 10.4 PGR ESR1
57 lung leiomyoma 10.4 PGR ESR1
58 vulvar syringoma 10.4 PGR ESR1
59 trigonitis 10.4 PGR ESR1
60 adult type testicular granulosa cell tumor 10.4 PGR ESR1
61 breast adenoid cystic carcinoma 10.4 PGR ERBB2
62 osteogenic sarcoma 10.4
63 infant gynecomastia 10.4
64 meningothelial meningioma 10.4 SERPINA3 PGR
65 skull base cancer 10.4 SERPINA3 PGR
66 xanthogranulomatous cholecystitis 10.4 TP53 SERPINA3
67 mammographic density 10.4 PGR ESR1
68 skull base meningioma 10.4 SERPINA3 PGR
69 linitis plastica 10.4 PGR ERBB2
70 gastric papillary adenocarcinoma 10.4 TP53 ERBB2
71 pulmonary vein leiomyosarcoma 10.4 PGR CD34
72 sebaceous adenoma 10.4 SERPINA3 ESR1
73 vagina leiomyoma 10.4 PGR CD34
74 lung meningioma 10.4 PGR CD34
75 breast squamous cell carcinoma 10.4 TP53 ERBB2
76 liver sarcoma 10.4 SERPINA3 CD34
77 parotid gland cancer 10.4 TP53 ERBB2
78 pleomorphic adenoma carcinoma 10.4 TP53 ERBB2
79 gastric squamous cell carcinoma 10.4 SERPINA3 KRT5
80 papillary adenoma 10.3 TP53 KRT5
81 pregnancy adenoma 10.3 PGR KRT5
82 breast cystic hypersecretory carcinoma 10.3 KRT5 ERBB2
83 progesterone resistance 10.3 PGR ESR1
84 external ear carcinoma 10.3 PGR KRT5
85 chondrosarcoma 10.3
86 malignant fibroxanthoma 10.3
87 constipation 10.3
88 fibrous histiocytoma 10.3
89 48,xyyy 10.3
90 undifferentiated pleomorphic sarcoma 10.3
91 glomangiosarcoma 10.3 TP53 CD34
92 intravascular fasciitis 10.3 ESR1 CD34
93 cerebellum cancer 10.3 TP53 SERPINA3
94 vulva basal cell carcinoma 10.3 KRT5 ERBB2
95 large intestine adenocarcinoma 10.3 TP53 ERBB2
96 pediatric angiosarcoma 10.3 TP53 CD34
97 cervical adenomyoma 10.3 PGR MME
98 gender identity disorder 10.3 PGR ESR1
99 fibromatosis 10.3
100 breast myoepithelial carcinoma 10.3 PGR KRT5
101 malignant spiradenoma 10.3 TP53 KRT5
102 mucoepidermoid esophageal carcinoma 10.3 TP53 KRT5
103 tenosynovial giant cell tumor 10.3 SERPINA3 CD34
104 breast hemangioma 10.3 TP53 CD34
105 cervical serous adenocarcinoma 10.3 PGR MME
106 ovarian carcinosarcoma 10.3 TP53 ERBB2
107 recurrent respiratory papillomatosis 10.3 ERBB2 EGFR
108 cystic lymphangioma 10.3 SERPINA3 CD34
109 atypical polypoid adenomyoma 10.3 MME MED12
110 granulosa cell tumor of the ovary 10.3 TP53 ERBB2
111 lung leiomyosarcoma 10.3 KRT5 CD34
112 esophageal adenosquamous carcinoma 10.3 KRT5 ERBB2
113 necrotizing sialometaplasia 10.3 TP53 KRT5
114 spermatic cord cancer 10.3 KRT5 CD34
115 gastrointestinal lymphoma 10.3 SERPINA3 MME
116 cellular leiomyoma 10.3 MME MED12
117 myofibroma 10.3 SERPINA3 CD34
118 ovarian endometrial cancer 10.3 SERPINA3 PGR ESR1
119 eccrine sweat gland cancer 10.3 TP53 KRT5
120 infantile digital fibromatosis 10.2
121 eccrine acrospiroma 10.2 TP53 KRT5
122 pediatric fibrosarcoma 10.2 SERPINA3 CD34
123 large cell acanthoma 10.2 TP53 KRT5
124 papillary carcinoma 10.2 PGR ESR1 ERBB2
125 pancreatic mucinous cystadenoma 10.2 PGR MME
126 pelvic lipomatosis 10.2 MED12 CD34
127 testicular fibroma 10.2 KRT5 CD34
128 glassy cell carcinoma of the cervix 10.2 PGR ESR1 ERBB2
129 cutaneous solitary mastocytoma 10.2 SERPINA3 KIT
130 breast juvenile papillomatosis 10.2 PGR ESR1 ERBB2
131 type c thymoma 10.2 SERPINA3 KIT
132 oncocytic breast carcinoma 10.2 PGR ESR1 ERBB2
133 clear cell meningioma 10.2 PGR CD34
134 esophagus verrucous carcinoma 10.2 TP53 EGFR
135 metatypical basal cell carcinoma 10.2 KRT5 CD34
136 hepatoid adenocarcinoma 10.2 SERPINA3 EGFR
137 adult malignant schwannoma 10.2 TP53 CD34
138 well-differentiated liposarcoma 10.2
139 breast neuroendocrine neoplasm 10.2 PGR ESR1 ERBB2
140 pacinian tumor 10.2 MME CD34
141 frontal lobe neoplasm 10.2 TP53 EGFR
142 progesterone-receptor positive breast cancer 10.2 PGR ESR1 ERBB2
143 pleomorphic lipoma 10.2 SERPINA3 PGR CD34
144 benign mesenchymoma 10.2 KRT5 CD34
145 signet ring cell adenocarcinoma 10.2 TP53 SERPINA3 ERBB2
146 serous cystadenocarcinoma 10.2 TP53 PGR ERBB2
147 estrogen excess 10.2 PGR ESR1
148 apocrine adenosis of breast 10.2 TP53 PGR ERBB2
149 papillary adenocarcinoma 10.2 TP53 PGR ERBB2
150 glandular cystitis 10.2 TP53 MME
151 teeth hard tissue disease 10.2 PGR ESR1 ERBB2
152 gastric diffuse adenocarcinoma 10.2 TP53 PGR ERBB2
153 inflammatory liposarcoma 10.2 MME CD34
154 bartholin's gland adenoma 10.2 TP53 PGR ESR1
155 bartholin's gland benign neoplasm 10.2 TP53 PGR ESR1
156 vestibular gland benign neoplasm 10.2 TP53 PGR ESR1
157 ovarian seromucinous carcinoma 10.2 TP53 PGR ESR1
158 uterine corpus serous adenocarcinoma 10.2 TP53 ERBB2
159 benign breast adenomyoepithelioma 10.2 KRT5 EGFR
160 subareolar duct papillomatosis 10.2 MME KRT5
161 central nervous system leukemia 10.2 MME CD34
162 biliary tract cancer 10.2 ERBB2 EGFR
163 nipple neoplasm 10.2 MME KRT5
164 celiac disease 1 10.2
165 lymphoma 10.2
166 desmoid tumor 10.2
167 prostate malignant phyllodes tumor 10.2
168 mastitis 10.2
169 ovarian brenner tumor 10.2
170 breast pericanalicular fibroadenoma 10.2
171 rhabdomyosarcoma 10.2
172 seminal vesicle tumor 10.2
173 prostate sarcoma 10.2
174 breast rhabdomyosarcoma 10.2
175 holoprosencephaly 10.2
176 pleomorphic liposarcoma 10.2
177 breast fibrosarcoma 10.2
178 paraplegia 10.2
179 breast giant fibroadenoma 10.2
180 sarcomatosis 10.2
181 hypoglycemia 10.2
182 chromosomal triplication 10.2
183 prostatic stromal proliferation of uncertain malignant potential 10.2
184 posttransplant acute limbic encephalitis 10.2
185 rare soft tissue tumor 10.2
186 clear cell adenocarcinoma 10.2 TP53 PGR ESR1
187 endosalpingiosis 10.2 TP53 PGR ESR1
188 fallopian tube endometrioid adenocarcinoma 10.2 MME ERBB2
189 adenoid squamous cell carcinoma 10.2 KRT5 CD34
190 vaginal cancer 10.2 TP53 PGR ESR1
191 endocervical carcinoma 10.2 TP53 PGR ESR1
192 endocervical adenocarcinoma 10.2 TP53 PGR ESR1
193 fibrosarcoma of bone 10.2 SERPINA3 KIT
194 sclerosing hepatic carcinoma 10.2 MME CD34
195 clear cell basal cell carcinoma 10.2 TP53 KRT5
196 cervix erosion 10.2 MME KRT5
197 spinal cord sarcoma 10.2 KIT CD34
198 pelvic organ prolapse 10.2 TP53 PGR ESR1
199 islet cell tumor 10.2
200 spinal cord oligodendroglioma 10.2 TP53 EGFR
201 gallbladder leiomyoma 10.2 KIT CD34
202 bladder leiomyoma 10.2 KIT CD34
203 urethra clear cell adenocarcinoma 10.2 TP53 KRT5
204 vulvar leiomyoma 10.2 PGR ESR1 CD34
205 vulvar benign neoplasm 10.1 PGR ESR1 CD34
206 breast hemangiopericytoma 10.1 KIT CD34
207 small intestinal sarcoma 10.1 KIT CD34
208 small intestine leiomyosarcoma 10.1 KIT CD34
209 colon leiomyosarcoma 10.1 KIT CD34
210 clear cell hidradenoma 10.1 MME KRT5
211 hidradenoma 10.1 MME KRT5
212 intratubular embryonal carcinoma 10.1 TP53 KIT
213 lipid-rich breast carcinoma 10.1 PGR KRT5 ERBB2
214 colon leiomyoma 10.1 MED12 KIT
215 pulmonary artery leiomyosarcoma 10.1 MME CD34
216 endometrial hyperplasia 10.1 TP53 PGR ESR1
217 breast mucinous carcinoma 10.1 PGR KRT5 ERBB2
218 mucinous tubular and spindle renal cell carcinoma 10.1 MME CD34
219 nephrogenic adenoma of the urethra 10.1 MME KRT5
220 urethral benign neoplasm 10.1 MME KRT5
221 gastroesophageal junction adenocarcinoma 10.1 ERBB2 EGFR
222 gallbladder leiomyosarcoma 10.1 KIT CD34
223 deep leiomyoma 10.1 KIT CD34
224 respiratory failure 10.1
225 breast liposarcoma 10.1
226 papillary squamous carcinoma 10.1 KRT5 EGFR
227 eccrine sweat gland neoplasm 10.1 MME KRT5
228 heart leiomyosarcoma 10.1 KIT CD34
229 balloon cell malignant melanoma 10.1 MME KRT5
230 plexiform schwannoma 10.1 KIT CD34
231 small intestine leiomyoma 10.1 KIT CD34
232 bladder clear cell adenocarcinoma 10.1 TP53 MME
233 retroperitoneal hemangiopericytoma 10.1 KIT CD34
234 chordoid glioma 10.1 TP53 PGR
235 jejunal neoplasm 10.1 KIT CD34
236 epididymis adenocarcinoma 10.1 MME KRT5
237 epididymis cancer 10.1 MME KRT5
238 retroperitoneal leiomyosarcoma 10.1 KIT CD34
239 paronychia 10.1 SERPINA3 ERBB2 EGFR
240 polyclonal hypergammaglobulinemia 10.1 SERPINA3 MME
241 mixed glioma 10.1 TP53 EGFR
242 cutaneous ganglioneuroma 10.1 KIT CD34
243 nasal cavity olfactory neuroblastoma 10.1 MME KRT5
244 pharynx cancer 10.1 TP53 SERPINA3 EGFR
245 liver leiomyosarcoma 10.1 KIT CD34
246 ceruminous adenocarcinoma 10.1 KRT5 KIT
247 liver fibroma 10.1 KRT5 KIT
248 fasciitis 10.1 TP53 ESR1 CD34
249 breast cancer 10.1
250 kidney cancer 10.1
251 dermatitis 10.1
252 47,xyy 10.1
253 overgrowth syndrome 10.1
254 skin benign neoplasm 10.1 SERPINA3 KRT5 CD34
255 intravenous leiomyomatosis 10.1 PGR MME ESR1
256 retroperitoneal sarcoma 10.1 KIT CD34
257 bone squamous cell carcinoma 10.1 TP53 EGFR
258 urethra leiomyoma 10.1 MME KIT
259 sebaceous adenocarcinoma 10.1 TP53 KRT5 ERBB2
260 plasma cell neoplasm 10.1 TP53 SERPINA3 MME
261 peritoneal mesothelioma 10.1 PGR ESR1 EGFR
262 breast leiomyosarcoma 10.0 KIT CD34
263 dermis tumor 10.0 SERPINA3 MME CD34
264 combined thymoma 10.0 KRT5 KIT
265 cutaneous fibrous histiocytoma 10.0 SERPINA3 MME CD34
266 intestinal benign neoplasm 10.0 TP53 SERPINA3 EGFR
267 thymus clear cell carcinoma 10.0 KRT5 KIT
268 gastrointestinal system benign neoplasm 10.0 TP53 SERPINA3 EGFR
269 skin tag 10.0 SERPINA3 CD34
270 cervical polyp 10.0 PGR MME CD34
271 esophagus adenocarcinoma 10.0 TP53 ERBB2 EGFR
272 gallbladder adenocarcinoma 10.0 TP53 ERBB2 EGFR
273 rectum adenocarcinoma 10.0 TP53 ERBB2 EGFR
274 wolffian duct adenocarcinoma 10.0 TP53 MME ESR1
275 borst-jadassohn intraepidermal carcinoma 10.0 TP53 KRT5
276 lymphangioleiomyomatosis 10.0 PGR ESR1 EGFR
277 vulva cancer 10.0 TP53 ERBB2 EGFR
278 endometrial clear cell adenocarcinoma 10.0 TP53 MME ESR1
279 cardiogenic shock 10.0
280 childhood medulloblastoma 10.0 TP53 ERBB2 EGFR
281 fibroma 10.0
282 hypoglycemic coma 10.0
283 hyperinsulinism 10.0
284 subacute delirium 10.0
285 pseudoangiomatous stromal hyperplasia 10.0
286 chordoma 10.0 TP53 SERPINA3 EGFR
287 pancreatic ductal carcinoma 10.0 TP53 ERBB2 EGFR
288 cystadenocarcinoma 10.0 TP53 SERPINA3 PGR ERBB2
289 vagina leiomyosarcoma 10.0 PGR KIT ESR1
290 colon sarcoma 10.0 KIT CD34
291 breast myofibroblastoma 10.0 MME ESR1 CD34
292 hair disease 10.0 TP53 ERBB2 EGFR
293 bile duct adenocarcinoma 10.0 TP53 ERBB2 EGFR
294 juvenile nasopharyngeal angiofibroma 10.0 PGR KIT ESR1
295 dowling-degos disease 1 10.0 KRT5 KIT
296 eccrine papillary adenocarcinoma 10.0 PGR MME KRT5
297 intussusception 10.0
298 ocular motor apraxia 10.0
299 prostatic hyperplasia, benign 10.0
300 aneurysmal bone cysts 10.0
301 myxoid liposarcoma 10.0
302 deficiency anemia 10.0
303 breast abscess 10.0
304 hypogonadotropic hypogonadism 10.0
305 pulmonary edema 10.0
306 obstructive jaundice 10.0
307 squamous cell papilloma 10.0
308 neuroendocrine carcinoma 10.0
309 giant cell tumor 10.0
310 prostatic adenoma 10.0
311 lynch syndrome 10.0
312 bone giant cell tumor 10.0
313 mixed liposarcoma 10.0
314 myxoid chondrosarcoma 10.0
315 severe combined immunodeficiency 10.0
316 megakaryocytic leukemia 10.0
317 krukenberg carcinoma 10.0
318 triploidy 10.0
319 bizarre leiomyoma 10.0 TP53 PGR MED12 ESR1
320 intrahepatic cholangiocarcinoma 10.0 TP53 ERBB2 EGFR
321 lymphoepithelioma-like thymic carcinoma 10.0 KRT5 KIT
322 meckel diverticulum 10.0 KIT CD34
323 malignant spindle cell melanoma 10.0 SERPINA3 KIT CD34
324 testicular disease 10.0 TP53 SERPINA3 KIT
325 uterine anomalies 10.0 TP53 SERPINA3 PGR ESR1
326 hemangiopericytoma, malignant 10.0 SERPINA3 KIT CD34
327 comedo carcinoma 10.0 TP53 PGR ESR1 ERBB2
328 synovium cancer 9.9 SERPINA3 KIT CD34
329 lipomatosis, multiple 9.9 SERPINA3 KIT CD34
330 female reproductive endometrioid cancer 9.9 TP53 PGR ESR1 ERBB2
331 apocrine sweat gland neoplasm 9.9 SERPINA3 PGR KRT5 ERBB2
332 mature teratoma 9.9 TP53 KIT ERBB2
333 leukemia, acute lymphoblastic 3 9.9 TP53 MME CD34
334 cavernous hemangioma 9.9 SERPINA3 KIT CD34
335 prostate stromal sarcoma 9.9 PGR KIT CD34
336 intestinal obstruction 9.9 SERPINA3 KIT CD34
337 fallopian tube carcinoma 9.9 TP53 PGR ESR1 ERBB2
338 giant cell glioblastoma 9.9 TP53 EGFR CD34
339 esophageal basaloid squamous cell carcinoma 9.9 TP53 KRT5 EGFR
340 mastocytosis, cutaneous 9.9 SERPINA3 KIT CD34
341 blood coagulation disease 9.9 SERPINA3 KIT CD34
342 micronodular basal cell carcinoma 9.9 TP53 MME KRT5
343 teratoma 9.9 TP53 KIT ESR1
344 cowden syndrome 9.9 TP53 ERBB2 EGFR
345 adenofibroma 9.9 TP53 MME
346 keratinizing squamous cell carcinoma 9.9 TP53 KRT5 EGFR
347 autosomal genetic disease 9.9 TP53 SERPINA3 ESR1
348 central nervous system cancer 9.9 TP53 SERPINA3 EGFR
349 verrucous carcinoma 9.9 TP53 KRT5 EGFR
350 inverted papilloma 9.9 TP53 KRT5 EGFR
351 esophageal disease 9.9 TP53 ERBB2 EGFR
352 pleural cancer 9.9 TP53 KRT5 EGFR
353 pleural disease 9.9 TP53 KRT5 EGFR
354 central epithelioid sarcoma 9.9 MME KRT5 CD34
355 vulvar proximal-type epithelioid sarcoma 9.9 MME KRT5 CD34
356 breast papillary carcinoma 9.9 PGR KRT5 ESR1 ERBB2
357 lipid-rich carcinoma 9.9 PGR KRT5 ESR1 ERBB2
358 intracystic papillary adenoma 9.9 PGR KRT5 ESR1 ERBB2
359 gliofibroma 9.9 TP53 KIT CD34
360 glomangiomatosis 9.9 TP53 KIT CD34
361 conventional fibrosarcoma 9.9 TP53 KIT CD34
362 neurofibrosarcoma 9.9 TP53 KIT CD34
363 sarcoma, synovial 9.9 SERPINA3 KIT CD34
364 plexiform neurofibroma 9.9 TP53 KIT CD34
365 keratosis 9.9 TP53 KRT5 EGFR
366 adenomyoma 9.9 PGR MME MED12 ESR1
367 nasal cavity cancer 9.9 TP53 KRT5
368 cystic nephroma 9.8 PGR MME KIT
369 perivascular epithelioid cell tumor 9.8 PGR MME KIT
370 inflammatory myofibroblastic tumor 9.8 TP53 KIT CD34
371 breast scirrhous carcinoma 9.8 PGR ESR1 ERBB2 EGFR
372 progesterone-receptor negative breast cancer 9.8 PGR ESR1 ERBB2 EGFR
373 ovarian cystadenocarcinoma 9.8 TP53 SERPINA3 ERBB2 EGFR
374 esophagus sarcoma 9.8 KRT5 KIT CD34
375 amelogenesis imperfecta, type ig 9.8 PGR ESR1 ERBB2 EGFR
376 estrogen-receptor negative breast cancer 9.8 PGR ESR1 ERBB2 EGFR
377 paget disease, extramammary 9.8 KRT5 ERBB2
378 mediastinal cancer 9.8 KRT5 KIT CD34
379 nodular malignant melanoma 9.8 TP53 KIT
380 bone marrow cancer 9.8 TP53 KIT CD34
381 gallbladder disease 9.8 TP53 SERPINA3 ERBB2 EGFR
382 exanthem 9.8 KIT ERBB2 EGFR
383 autonomic nervous system neoplasm 9.8 TP53 SERPINA3 ERBB2 EGFR
384 bladder benign neoplasm 9.8 MME KIT
385 barrett esophagus 9.8 TP53 ERBB2 EGFR
386 hemangioblastoma 9.8 MME EGFR CD34
387 primary peritoneal carcinoma 9.8 TP53 PGR ERBB2 EGFR
388 oral cavity cancer 9.8 TP53 SERPINA3 ERBB2 EGFR
389 bone cancer 9.8 TP53 SERPINA3 ESR1 EGFR
390 cervical mucinous adenocarcinoma 9.8 TP53 PGR MME ESR1
391 transitional cell carcinoma 9.8 TP53 ERBB2 EGFR
392 anus cancer 9.8 TP53 KIT EGFR
393 adenomyosis 9.8 TP53 PGR MME ESR1
394 thymic carcinoma 9.8 TP53 KIT EGFR
395 leiomyomatosis 9.8 PGR MED12 KIT ESR1
396 breast leiomyoma 9.8 PGR MME ESR1 CD34
397 endobronchial leiomyoma 9.8 MME KIT CD34
398 vaginal endometrial stromal sarcoma 9.8 PGR MME ESR1 CD34
399 cervical adenocarcinoma 9.8 TP53 ESR1 ERBB2 EGFR
400 small cell carcinoma 9.8 TP53 KIT EGFR
401 thymoma 9.7 TP53 KIT EGFR
402 small cell cancer of the lung 9.7 TP53 KIT EGFR
403 thoracic cancer 9.7 TP53 SERPINA3 PGR ESR1 ERBB2
404 sarcomatoid squamous cell skin carcinoma 9.7 SERPINA3 MME KRT5 CD34
405 liver leiomyoma 9.7 PGR KIT ESR1 CD34
406 peritoneum cancer 9.7 TP53 KRT5 ERBB2 EGFR
407 connective tissue benign neoplasm 9.7 TP53 SERPINA3 KIT CD34
408 apocrine adenocarcinoma 9.7 SERPINA3 PGR KRT5 ESR1 ERBB2
409 sweat gland disease 9.7 SERPINA3 PGR KRT5 ESR1 ERBB2
410 skeletal muscle cancer 9.7 TP53 SERPINA3 KIT CD34
411 muscle cancer 9.7 TP53 SERPINA3 KIT CD34
412 dermatofibrosarcoma protuberans 9.7 TP53 SERPINA3 KIT CD34
413 pancytopenia 9.7 TP53 SERPINA3 KIT CD34
414 cystadenoma 9.7 SERPINA3 PGR MME KIT
415 hemangioma 9.6 TP53 PGR KIT CD34
416 heart cancer 9.6 SERPINA3 KRT5 KIT CD34
417 respiratory system benign neoplasm 9.6 TP53 KRT5 EGFR CD34
418 cholangiocarcinoma 9.6 TP53 MME ERBB2 EGFR
419 uterus leiomyosarcoma 9.6 PGR KRT5 KIT CD34
420 sweat gland cancer 9.6 TP53 PGR KRT5 ESR1 ERBB2
421 ovarian serous cystadenocarcinoma 9.6 TP53 SERPINA3 PGR ERBB2 EGFR
422 angiomyolipoma 9.6 PGR MME KIT ESR1
423 pleomorphic carcinoma 9.6 TP53 PGR KIT EGFR
424 melanoma, cutaneous malignant 1 9.6 TP53 KIT EGFR
425 uterine body mixed cancer 9.6 TP53 KIT ERBB2 EGFR
426 uterine corpus cancer 9.6 TP53 PGR ESR1 ERBB2 EGFR
427 endometrial adenocarcinoma 9.6 TP53 PGR ESR1 ERBB2 EGFR
428 sporadic breast cancer 9.6 TP53 PGR ESR1 ERBB2 EGFR
429 estrogen-receptor positive breast cancer 9.6 TP53 PGR ESR1 ERBB2 EGFR
430 colorectal adenocarcinoma 9.5 TP53 KIT ERBB2 EGFR
431 cutaneous adenocystic carcinoma 9.5 PGR MME KRT5 KIT
432 gliosarcoma 9.5 TP53 SERPINA3 ERBB2 EGFR CD34
433 bladder urothelial carcinoma 9.5 TP53 KIT ERBB2 EGFR
434 breast metaplastic carcinoma 9.5 PGR KRT5 ESR1 ERBB2 EGFR
435 breast osteosarcoma 9.5 PGR MME KRT5 ESR1 ERBB2
436 large cell carcinoma 9.5 KRT5 KIT ERBB2 EGFR
437 neurofibroma 9.5 TP53 KIT EGFR CD34
438 mucoepidermoid carcinoma 9.5 TP53 SERPINA3 KRT5 ERBB2 EGFR
439 malignant peripheral nerve sheath tumor 9.5 TP53 KIT EGFR CD34
440 thymus gland disease 9.5 TP53 KRT5 KIT EGFR
441 thymus cancer 9.5 TP53 KRT5 KIT EGFR
442 skin squamous cell carcinoma 9.5 TP53 KRT5 KIT EGFR
443 sweat gland neoplasm 9.4 TP53 MME KRT5 ERBB2 CD34
444 large cell neuroendocrine carcinoma 9.4 PGR KIT ESR1 ERBB2 EGFR
445 salivary gland carcinoma 9.4 TP53 SERPINA3 KIT ERBB2 EGFR
446 ovary adenocarcinoma 9.4 TP53 SERPINA3 PGR ESR1 ERBB2 EGFR
447 malignant ovarian surface epithelial-stromal neoplasm 9.4 TP53 SERPINA3 PGR ESR1 ERBB2 EGFR
448 ovary epithelial cancer 9.4 TP53 SERPINA3 PGR ESR1 ERBB2 EGFR
449 glioma susceptibility 1 9.3 TP53 ERBB2 EGFR
450 endometrial stromal sarcoma 9.3 TP53 PGR MME KIT ESR1
451 vagina sarcoma 9.3 PGR MME KIT ESR1 CD34
452 adult mesoblastic nephroma 9.3 PGR MME KIT ESR1 CD34
453 cardiovascular cancer 9.3 TP53 SERPINA3 MME KIT CD34
454 vascular cancer 9.3 TP53 SERPINA3 MME KIT CD34
455 lymphatic system cancer 9.3 TP53 SERPINA3 MME KIT CD34
456 lymphatic system disease 9.3 TP53 SERPINA3 MME KIT CD34
457 leukocyte disease 9.3 TP53 SERPINA3 MME KIT CD34
458 connective tissue cancer 9.3 TP53 SERPINA3 KIT EGFR CD34
459 uterine benign neoplasm 9.3 TP53 PGR MME MED12 ESR1 CD34
460 pancreatic adenocarcinoma 9.3 TP53 KIT ESR1 ERBB2 EGFR
461 gastric adenocarcinoma 9.3 TP53 KIT ESR1 ERBB2 EGFR
462 thyroid gland cancer 9.3 TP53 KIT ESR1 ERBB2 EGFR
463 myocardial infarction 9.3 TP53 SERPINA3 MME ESR1 CD34
464 hematologic cancer 9.3 TP53 SERPINA3 MME KIT CD34
465 leber congenital amaurosis 9.3 TP53 SERPINA3 MME KIT CD34
466 glioblastoma multiforme 9.3 TP53 KIT ESR1 ERBB2 EGFR
467 ewing sarcoma 9.2 TP53 KIT ERBB2 EGFR CD34
468 leukemia, chronic myeloid 9.2 TP53 KIT ERBB2 EGFR CD34
469 dilated cardiomyopathy 9.2 TP53 SERPINA3 ERBB2 EGFR CD34
470 intraductal breast neoplasm 9.2 TP53 PGR MME KRT5 ESR1 ERBB2
471 luminal breast carcinoma 9.2 TP53 PGR KRT5 ESR1 ERBB2 EGFR
472 pre-malignant neoplasm 9.2 TP53 PGR KRT5 ESR1 ERBB2 EGFR
473 breast carcinoma in situ 9.2 TP53 PGR KRT5 ESR1 ERBB2 EGFR
474 breast ductal carcinoma 9.2 TP53 PGR KRT5 ESR1 ERBB2 EGFR
475 neuroblastoma 9.2 TP53 KIT ESR1 ERBB2 EGFR
476 renal cell carcinoma, papillary, 1 9.2 TP53 MME KIT ERBB2 EGFR
477 mucinous adenocarcinoma 9.1 TP53 PGR KIT ESR1 ERBB2 EGFR
478 reproductive organ benign neoplasm 9.1 TP53 SERPINA3 PGR MME MED12 ESR1
479 ovarian disease 9.1 TP53 PGR KIT ESR1 ERBB2 EGFR
480 peripheral nervous system neoplasm 9.1 TP53 SERPINA3 KIT ERBB2 EGFR CD34
481 adenosquamous carcinoma 9.0 TP53 SERPINA3 PGR KRT5 KIT EGFR
482 vulvar disease 9.0 TP53 PGR KIT ERBB2 EGFR CD34
483 salivary gland disease 9.0 TP53 SERPINA3 KRT5 KIT ERBB2 EGFR
484 smooth muscle tumor 8.9 SERPINA3 PGR MME MED12 KIT ESR1
485 leukemia, chronic lymphocytic 8.8 TP53 MME KIT ERBB2 EGFR CD34
486 cell type benign neoplasm 8.8 TP53 SERPINA3 PGR KIT ESR1 EGFR
487 gastric cancer 8.8 TP53 SERPINA3 PGR KIT ESR1 ERBB2
488 oropharynx cancer 8.8 TP53 SERPINA3 PGR KRT5 KIT ERBB2
489 hypertension, essential 8.8 TP53 MME KIT ESR1 EGFR CD34
490 adenoid cystic carcinoma 8.8 TP53 SERPINA3 PGR KRT5 KIT ERBB2
491 suppression of tumorigenicity 12 8.8 TP53 SERPINA3 KRT5 KIT ESR1 ERBB2
492 basal cell carcinoma 8.7 TP53 MME KRT5 KIT EGFR CD34
493 lung cancer susceptibility 3 8.7 TP53 SERPINA3 KRT5 KIT ESR1 ERBB2
494 myoma 8.7 PGR MME MED12 KIT ESR1 EGFR
495 uterine carcinosarcoma 8.7 TP53 PGR MME KIT ESR1 ERBB2
496 myeloma, multiple 8.6 TP53 MME KIT ESR1 ERBB2 EGFR
497 meningioma, familial 8.6 TP53 SERPINA3 PGR KIT ESR1 ERBB2
498 wilms tumor 1 8.6 TP53 PGR MED12 KIT ESR1 ERBB2
499 tonsil cancer 8.5 TP53 SERPINA3 PGR KRT5 KIT ESR1
500 prostate cancer 8.5 TP53 SERPINA3 PGR MME KRT5 ESR1
501 endometrial cancer 8.5 TP53 SERPINA3 PGR MME KIT ESR1
502 muscular disease 8.4 TP53 SERPINA3 PGR MME KIT ESR1
503 leukemia, acute myeloid 8.4 TP53 SERPINA3 MME KIT ESR1 ERBB2
504 hepatocellular carcinoma 8.3 TP53 SERPINA3 MME KIT ESR1 ERBB2
505 thoracic benign neoplasm 8.1 TP53 SERPINA3 PGR MME MED12 KRT5
506 breast benign neoplasm 8.1 TP53 SERPINA3 PGR MME MED12 KRT5
507 mixed cell type cancer 7.8 TP53 SERPINA3 PGR MME KRT5 KIT

Graphical network of the top 20 diseases related to Breast Malignant Phyllodes Tumor:



Diseases related to Breast Malignant Phyllodes Tumor

Symptoms & Phenotypes for Breast Malignant Phyllodes Tumor

MGI Mouse Phenotypes related to Breast Malignant Phyllodes Tumor:

45 (showing 11, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.19 CD34 EGFR ERBB2 ESR1 KIT MED12
2 integument MP:0010771 10.1 CD34 EGFR ERBB2 ESR1 KIT KRT5
3 embryo MP:0005380 9.98 EGFR ERBB2 ESR1 KIT MED12 PGR
4 limbs/digits/tail MP:0005371 9.97 EGFR ERBB2 ESR1 KIT KRT5 MED12
5 craniofacial MP:0005382 9.95 EGFR ERBB2 KIT KRT5 MED12 TP53
6 digestive/alimentary MP:0005381 9.93 EGFR ERBB2 ESR1 KIT KRT5 TP53
7 muscle MP:0005369 9.87 EGFR ERBB2 ESR1 KIT MOCS2 PGR
8 neoplasm MP:0002006 9.8 CD34 EGFR ERBB2 ESR1 KIT PGR
9 no phenotypic analysis MP:0003012 9.63 EGFR ESR1 KIT KRT5 PGR TP53
10 normal MP:0002873 9.5 EGFR ERBB2 ESR1 KIT MED12 PGR
11 skeleton MP:0005390 9.17 EGFR ERBB2 ESR1 KIT MED12 PGR

Drugs & Therapeutics for Breast Malignant Phyllodes Tumor

Drugs for Breast Malignant Phyllodes Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 8, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fluorouracil Approved Phase 1 51-21-8 3385
2
Belinostat Approved, Investigational Phase 1 866323-14-0
3
Parathyroid hormone Approved, Investigational Phase 1 9002-64-6
4 Immunologic Factors Phase 1
5 Histone Deacetylase Inhibitors Phase 1
6 Antimetabolites Phase 1
7 Androgens Phase 1
8 Immunosuppressive Agents Phase 1

Interventional clinical trials:

(showing 3, show less)
# Name Status NCT ID Phase Drugs
1 A Phase I Safety, Pharmacodynamic, Anti-Tumor Activity, and Pharmacokinetic Study of PXD101 Alone and in Combination With 5-Fluorouracil in Patients With Advanced Solid Tumors Completed NCT00413322 Phase 1 belinostat;5-Fluorouracil (5-FU)
2 A Prospective Study of Adjuvant Radiation Therapy After Resection of Borderline and Malignant Phyllodes Tumors Completed NCT00003404
3 A Prospective Study of Partial Breast Adjuvant Radiation Therapy After Resection of Borderline and Malignant Phyllodes Tumors Recruiting NCT01089374

Search NIH Clinical Center for Breast Malignant Phyllodes Tumor

Genetic Tests for Breast Malignant Phyllodes Tumor

Anatomical Context for Breast Malignant Phyllodes Tumor

MalaCards organs/tissues related to Breast Malignant Phyllodes Tumor:

40
Breast, Prostate, Lung, Bone, Liver, Skin, Thymus

Publications for Breast Malignant Phyllodes Tumor

Articles related to Breast Malignant Phyllodes Tumor:

(showing 218, show less)
# Title Authors PMID Year
1
Lacrimal Sac Metastasis from Phyllodes Tumor of the Breast. 61
32037753 2020
2
Phyllodes Tumor of the Breast: A Clinicopathological Evaluation of 55 Cases. 61
31912011 2020
3
Radiotherapy with apatinib for recurrence of malignant phyllodes tumor of the breast: A case report. 61
32011486 2020
4
The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex vivo study. 61
31612021 2019
5
A rare case of a malignant phyllodes tumor of the breast associated with secretion of beta-human chorionic gonadotropin. 61
31192485 2019
6
Giant phyllodes tumor of the breast. 61
31486153 2019
7
Transcatheter arterial chemoembolization improves the resectability of malignant breast phyllodes tumor with angiosarcoma component: a case report. 61
31351458 2019
8
Cytologic diagnosis of metastatic malignant phyllodes tumor of the breast in pleural effusion. 61
30829462 2019
9
Malignant phyllodes tumor of the breast with liposarcomatous differentiation: A case report with imaging findings. 61
30834064 2019
10
Phyllodes tumors of the breast. The treatment results for 340 patients from a single cancer centre. 61
30521986 2019
11
Not Every Fat-Containing Lesion on Mammogram is a Benign Finding: Case Report and Review of Breast Malignant Phyllodes Tumor with Heterologous Liposarcomatous Differentiation. 61
31448161 2019
12
Phyllodes tumor of the breast: diagnosis, management and outcome during a 10-year experience. 61
31695485 2019
13
Recurrent borderline phyllodes tumor of the breast submitted to mastectomy and immediate reconstruction: Case report. 61
31195364 2019
14
Phyllodes tumor of the breast with nipple discharge: A case report. 61
30593154 2018
15
Percutaneous removal of benign phyllodes tumor of the breast: An alternative to surgery. 61
30251456 2018
16
Radiopathological characteristics and outcomes of phyllodes tumor of the breast in Malaysian women. 61
30075507 2018
17
Metastatic giant malignant phyllodes tumor of the breast. 61
29139587 2018
18
Phyllodes Tumor of the Breast: Ultrasound-Pathology Correlation. 61
29412020 2018
19
Early stage malignant phyllodes tumor case report. 61
29247967 2018
20
Malignant Phyllodes Tumor of the Breast with Metastasis to the Pancreas: A Case Report and Review of Literature. 61
30050709 2018
21
Phyllodes tumor masquerading as a fungating breast mass. 61
29250309 2017
22
Recurrent malignant phyllodes tumor of the breast: A case report. 61
29245318 2017
23
A rare presentation of malignant phyllodes tumor with bloody nipple discharge-report of a case. 61
28861384 2017
24
Radiation therapy for malignant phyllodes tumor of the breast: An analysis of SEER data. 61
28013032 2017
25
Giant phyllodes tumor of the breast with diffuse myxoid changes in an adolescent girl: a case report. 61
28458828 2017
26
Multiple metastatic malignant phyllodes tumor of the breast with tonsillar metastasis: a case report. 61
28103951 2017
27
A giant phyllodes tumor of the breast causing severe disfigurement. A case report. 61
28406095 2017
28
Clinicopathology and treatment of a giant malignant phyllodes tumor of the breast: A case report and literature review. 61
29121581 2017
29
Phyllodes Tumor of the Breast: Analysis of 48 Patients. 61
28331755 2016
30
A Giant Phyllodes Tumor of the Breast. 61
27746880 2016
31
A Case of Giant Borderline Phyllodes Tumor of the Breast Associated with Hypoglycemia. 61
27628602 2016
32
Insulin-like growth factor II messenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breast. 61
27137988 2016
33
Breast malignant phyllodes tumor with rare pelvic metastases and long-term overall survival: A case report and literature review. 61
27661051 2016
34
Giant malignant phyllodes tumor of the breast: A rare case report and literature review. 61
27347111 2016
35
Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates. 61
27362571 2016
36
Benign Phyllodes Tumor of the Breast Diagnosed After Ultrasound-Guided Vacuum-Assisted Biopsy: Surgical Excision or Wait-and-Watch? 61
26577125 2016
37
Treatment of Patients with Distant Metastases from Phyllodes Tumor of the Breast. 61
26464157 2016
38
The largest and neglected giant phyllodes tumor of the breast-A case report and literature review. 61
27475116 2016
39
Coexistence of malignant phyllodes tumor and her2-positive locally advanced breast cancer in distinct breasts: A case report. 61
26773878 2016
40
"Ruptured" malignant phyllodes tumor of the breast: a case report. 61
26952179 2016
41
Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast. 61
26625196 2016
42
Phyllodes Tumor of the Breast: 307 Treated Cases, the Largest Mexican Experience at a Single Breast Disease Institution. 61
28855932 2016
43
Metastatic Malignant Phyllodes Tumor of the Breast: An Aggressive Disease-Analysis of 7 Cases. 61
27065662 2015
44
Malignant phyllodes tumor of the breast with isolated intracranial metastases: A report. 61
26588634 2015
45
[Pulmonary Metastasis from a Phyllodes Tumor of the Breast Developing Sixteen Years after Initial Surgery]. 61
26555915 2015
46
Pleomorphic liposarcoma arising in a malignant phyllodes tumor of breast: A rare occurrence. 61
26881623 2015
47
Phyllodes tumor of the breast: a clinic-pathologic study of 77 cases in a Hispanic cohort. 61
26600624 2015
48
Phyllodes Tumor of the Breast With Malignant Melanoma Component: A Case Report. 61
26113664 2015
49
A Rare Case of Breast Malignant Phyllodes Tumor With Metastases to the Kidney: Case Report. 61
26287414 2015
50
Identification of clinically relevant alterations in phyllodes tumor of the breast by amplicon-based next-generation sequencing. 61
25900796 2015
51
Large Malignant Phyllodes Tumor of the Breast with Metastases to the Lungs. 61
26266007 2015
52
[MRI features of phyllodes tumor of the breast and the pathological study]. 61
25931218 2015
53
Benign phyllodes tumor of the breast recurring as a malignant phyllodes tumor and spindle cell metaplastic carcinoma. 61
25476122 2015
54
Malignant phyllodes tumor of the breast with liposarcomatous differentiation and intraductal hyperplasia. 61
25061020 2015
55
Phyllodes tumor of the breast metastasizing to the vulva. 61
25960902 2015
56
Phyllodes tumor: review of key imaging characteristics. 61
25792027 2015
57
How to approach phyllodes tumors of the breast? 61
26668526 2015
58
Synchronous bilateral primary breast malignant phyllodes tumor and carcinoma of the breast with Paget's disease: a case report and review of the literature. 61
26770378 2015
59
Malignant phyllodes tumor of the breast: treatment and prognosis. 61
25227987 2014
60
[The case of a giant malignant phyllodes tumor of the breast]. 61
25731379 2014
61
Malignant phyllodes tumor of the breast: a case study. 61
25253115 2014
62
In Situ Ductal Carcinoma Arising in Benign Phyllodes Tumor in 19-Year Old Patient: A Case Report. 61
28331678 2014
63
Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center. 61
25104281 2014
64
Phyllodes tumor of the breast: role of Axl and ST6GalNAcII in the development of mammary phyllodes tumors. 61
24961352 2014
65
Giant abdominal mass: a unique form of metastatic malignant phyllodes tumor of the breast. 61
24887716 2014
66
Malignant phyllodes tumor of the breast presenting with hypoglycemia: a case report and literature review. 61
25525388 2014
67
Analysis of patients with phyllodes tumor of the breast. 61
25931913 2014
68
Phyllodes tumor metastasis to the tonsil with synchronous undifferentiated carcinoma. 61
24747756 2014
69
Changes in the clinical characteristics, treatment options, and therapy outcomes in patients with phyllodes tumor of the breast during 55 years of experience. 61
24356679 2013
70
A young woman with a giant breast fibrosarcoma: a case report. 61
24255792 2013
71
An 11 kg Phyllodes tumor of the breast in combination with other multiple chronic diseases: Case report and review of the literature. 61
23946794 2013
72
Phyllodes tumor showing intraductal growth. 61
20490731 2013
73
[Phyllodes tumor of the breast: clinicopathologic analysis of 22 cases]. 61
23877808 2013
74
Phyllodes tumor of the breast: a retrospective study of the impact of histopathological factors in local recurrence and distant metastasis. 61
23563006 2013
75
Adrenal metastasis of a phyllodes tumor of the breast: Case report and review of the literature. 61
23792482 2013
76
[Usefulness of endoscopic resection for phyllodes tumor of the breast]. 61
23267964 2012
77
Factors associated with phyllodes tumor of the breast after core needle biopsy identifies fibroepithelial neoplasm. 61
22524977 2012
78
Malignant Phyllodes Tumor of the Breast Metastasizing to the Vulva: (18)F-FDG PET-CT Demonstrating Rare Metastasis from a Rare Tumor. 61
24900068 2012
79
Trichoblastic sarcoma with osteosarcomatous differentiation: evolution of one lesion with 3 histologic appearances over a 3-year period. 61
22688391 2012
80
Jejunal intussusception due to malignant phyllodes tumor of the breast. 61
22381472 2012
81
Long-term follow-up result of benign phyllodes tumor of the breast diagnosed and excised by ultrasound-guided vacuum-assisted breast biopsy. 61
22807941 2012
82
Malignant phyllodes tumors of the breast: a study in clinical practice. 61
23102073 2012
83
Phyllodes tumor of the breast: role of CD10 in predicting metastasis. 61
22006372 2012
84
[Malignant phyllodes tumor of the breast with liposarcomatous differentiation. Solution to case 40]. 61
21733534 2012
85
Anemia and jejunal intussusception: An unusual presentation for a metastatic phyllodes breast tumor. 61
22288047 2012
86
[Malignant phyllodes tumor of the breast after Hodgkin's disease]. 61
23396310 2012
87
Phyllodes tumor of the breast. 61
20890734 2011
88
Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors. 61
22121516 2011
89
Malignant phyllodes tumor of the breast: case report. 61
22012279 2011
90
Recurrent phyllodes tumor of the breast: defining the role for skin-sparing mastectomy and autologous reconstruction. 61
21432750 2011
91
Giant phyllodes tumor of the breast: Consequence of carelessness. 61
20843180 2011
92
CD34, CD117, and Ki-67 expression in phyllodes tumor of the breast: an immunohistochemical study of 33 cases. 61
21087983 2011
93
De novo phyllodes tumor in an adolescent female after liver transplantation. 61
19691525 2011
94
Difficulties in diagnosing and treating phyllodes tumor of the breast--case report. 61
21446340 2011
95
[Long-term results of surgical therapy for phyllodes tumor of the breast]. 61
21224712 2010
96
[Malignant phyllodes tumor of the breast with lymph node metastases shown by FDG PET-CT]. 61
20692076 2010
97
Extent of surgery in the management of phyllodes tumor of the breast: a retrospective multicenter study from India. 61
21358091 2010
98
Pulmonary artery obstruction due to a metastatic malignant phyllodes tumor of the breast. 61
20703865 2010
99
A case of a giant phyllodes tumor of the breast with hypoglycemia caused by high-molecular-weight insulin-like growth factor II. 61
19259766 2010
100
Synchronous Bilateral Benign Phyllodes Tumor of the Breast in a 32-year-old Woman. 61
29147179 2010
101
Phyllodes tumor of the breast: an update. 61
19434472 2010
102
Phyllodes tumor of the breast; a case series. 61
20568416 2010
103
Loss of SDHB and NF1 genes in a malignant phyllodes tumor of the breast as detected by oligo-array comparative genomic hybridization. 61
20082856 2010
104
Beta-human chorionic gonadotropin production associated with phyllodes tumor of the breast: an unusual paraneoplastic phenomenon. 61
19624411 2009
105
A phyllodes tumor in a child. 61
19539191 2009
106
Magnetic Resonance Imaging of a Benign Phyllodes Tumor of the Breast. 61
20847879 2009
107
Surgical treatment of giant recurrent breast phyllodes tumor. 61
19107368 2008
108
Malignant phyllodes tumor of the breast: local control rates with surgery alone. 61
18234448 2008
109
Benign phyllodes tumor of the breast with intracytoplasmic inclusion bodies identical to infantile digital fibromatosis. 61
18266786 2008
110
Giant borderline phyllodes tumor of the breast. 61
18312468 2008
111
Phyllodes tumor of the breast. 61
17931796 2008
112
Phyllodes tumor of the breast in an adolescent girl. 61
18231958 2008
113
Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin. 61
17932112 2007
114
Association of the BRCA1 missense variant R1699W with a malignant phyllodes tumor of the breast. 61
17574969 2007
115
Hypoglycemic coma secondary to big insulin-like growth factor II secretion by a giant phyllodes tumor of the breast. 61
17319862 2007
116
[Malignant phyllodes tumor of the breast with osteoclast-like giant cells: a case report]. 61
17568357 2007
117
Phyllodes tumor of the breast: correlation between MR findings and histologic grade. 61
17032912 2006
118
Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. 61
16998937 2006
119
Malignant phyllodes tumor with heterologous liposarcomatous differentiation and tubular adenoma-like epithelial component. 61
17003843 2006
120
Phyllodes tumor of the breast: the challenge persists. 61
16865317 2006
121
Phyllodes tumor with osteosarcomatous differentiation: a comparative immunohistochemical study between epithelial and mesenchymal cells. 61
17036527 2006
122
Prognostic factors of phyllodes tumor of the breast. 61
16704494 2006
123
A case of noninvasive ductal carcinoma arising in malignant phyllodes tumor. 61
16518067 2006
124
Radical surgical resection of a giant pleural metastasis of a malignant phyllodes tumor of the breast. 61
16308019 2005
125
[Phyllodes tumor of the breast: analysis of 8 patients]. 61
16012385 2005
126
Preoperative embolization of vascular phyllodes tumor of the breast. 61
15727999 2005
127
Phyllodes tumor of the breast: magnetic resonance imaging findings and surgical treatment. 61
15730463 2005
128
A case of phyllodes tumor of the breast with a lesion mimicking fibroadenoma. 61
16286914 2005
129
Phyllodes tumor of the seminal vesicle: case report and literature review. 61
15598315 2004
130
Cytogenetic findings in phyllodes tumor and fibroadenomas of the breast. 61
15474152 2004
131
Phyllodes tumor of the breast: local recurrence versus metastatic capacity. 61
15343504 2004
132
Scintimammographic findings of phyllodes tumor of the breast in a double-phase study with Tc-99m (V)DMSA and Tc-99m MIBI: a case report. 61
15342672 2004
133
Benign phyllodes tumor associated with Maffucci's syndrome. 61
15177431 2004
134
Magnetic resonance imaging of benign phyllodes tumors of the breast. 61
15125750 2004
135
Phyllodes tumor of the breast: case series of 40 patients. 61
15053081 2004
136
Prognostic factors in phyllodes tumor of the breast: are immunohistochemical biomarkers useful? 61
15077882 2004
137
Expression of p53 protein and Ki-67 antigen in phyllodes tumor of the breast. 61
15077883 2004
138
Massive infarction of a recurrent phyllodes tumor of the breast: MRI-findings. 61
15055329 2004
139
Malignant phyllodes tumor of the breast: review of the literature and case report of stromal overgrowth. 61
12689668 2003
140
Invasive lobular carcinoma arising in phyllodes tumor of the breast. 61
12743817 2003
141
Hypertrophic osteoarthropathy associated with metastatic phyllodes tumor. 61
12714885 2003
142
Malignant phyllodes tumor of the breast metastatic to the parotid gland diagnosed by fine needle aspiration biopsy. A case report. 61
12685197 2003
143
Radiologic-pathologic conferences of the University of Texas M.D. Anderson Cancer Center. Phyllodes tumor of the breast. 61
12540427 2003
144
Cystosarcoma phyllodes in a 13-year-old Muslim girl treated with conservative surgery: a case report. 61
12691328 2003
145
Malignant phyllodes tumor of the breast with predominant chondrosarcomatous differentiation. 61
14989497 2003
146
MRI in phyllodes tumor of the breast. Case reports. 61
12696294 2002
147
[Image of the month. Phyllodes tumor of the breast]. 61
12481463 2002
148
Clinicopathological study on phyllodes tumor of the breast. 61
12475436 2002
149
Phyllodes tumor of the breast. A cytomorphologic approach based on evaluation of epithelial cluster architecture. 61
11917581 2002
150
Malignant phyllodes tumor with pleomorphic liposarcomatous stroma diagnosed by fine needle aspiration cytology: a case report. 61
11843559 2002
151
Complex karyotype in a low grade phyllodes tumor of the breast. 61
11850078 2002
152
Clinical Analysis of Phyllodes Tumor of the Breast. 61
26680822 2001
153
Phyllodes tumor of the breast with actin inclusions in stromal cells: diagnosis by fine-needle aspiration cytology. 61
11477716 2001
154
Unusual clinical presentation of a rare case of phyllodes tumor of the breast in an adolescent girl. 61
11381432 2001
155
Malignant phyllodes tumor of the breast with expression of osteonectin and vinculin. 61
11350610 2001
156
A case of malignant phyllodes tumor of the breast with osteosarcomatous features. 61
11180771 2001
157
Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases. 61
11245343 2001
158
CD34, CD117, and actin expression in phyllodes tumor of the breast. 61
11104647 2000
159
Phyllodes tumor of the breast: EGFR family expression and relation to clinicopathological features. 61
11206334 2000
160
[Phyllodes tumor of the breast. Personal contribution of 21 cases]. 61
11227146 2000
161
Phyllodes tumor of the breast. A cytohistologic study of 80 cases. 61
11015981 2000
162
Malignant phyllodes tumor of the breast metastasizing to the pancreas: case report. 61
11039254 2000
163
[Primary breast tumor and malignant phyllodes tumor of the breast-- two rare cases demonstrated by technetium 99m scintimammography]. 61
10979402 2000
164
A Case of Phyllodes Tumor with Bloody Nipple Discharge in Juvenile Patient. 61
11091717 1999
165
Phyllodes tumor of the breast. 61
11155875 1999
166
[Phyllodes tumor of the breast with cystic portion: MR imaging with histopathological correlation]. 61
10388308 1999
167
Phyllodes tumors of the breast. 61
10101663 1999
168
[Pulmonary metastatic malignant phyllodes tumor showing multiple thin walled cavities]. 61
10087879 1999
169
Phyllodes Tumor of the Breast with a Grossly Malignant Appearance: A Case Report. 61
11091650 1998
170
The extent of surgery and prognosis of patients with phyllodes tumor of the breast. 61
9598867 1998
171
Malignant phyllodes tumor of the breast with hypoglycemia: report of a case. 61
9657015 1998
172
Is there a role for radiation therapy for the management of phyllodes tumor of the breast? 61
9885946 1998
173
Adjuvant radiotherapy for phyllodes tumor of breast. 61
9885942 1998
174
Tc-99m sestamibi and Tc-99m HMDP uptake in a malignant phyllodes tumor of the breast. 61
9262903 1997
175
Dynamic MR appearance of benign phyllodes tumor of the breast in a 20-year-old woman. 61
9311043 1997
176
Malignant cystosarcoma phyllodes tumor of the breast mainly composed of chondrosarcoma: a case report. 61
9065591 1997
177
Technetium-99m-sestamibi scintimammography of benign and malignant phyllodes tumors. 61
9095321 1997
178
Immunohistochemical profile of phyllodes tumors of the breast. 61
21594434 1996
179
Benign phyllodes tumor of the breast: MR imaging features. 61
8659370 1996
180
Phyllodes Tumor of the Breast: Pathology, Histogenesis, Diagnosis, and Treatment. 61
11091559 1996
181
[Phyllodes tumor of the breast: diagnostic and therapeutic problems]. 61
8929037 1996
182
The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. 61
8608483 1996
183
No rearrangement of the CHOP and TLS/FUS genes in two cases of phyllodes tumor of the breast. 61
8646752 1996
184
Progression of fibroadenoma to phyllodes tumor demonstrated by clonal analysis. 61
8625047 1995
185
Additional copies of 1q in sequential samples from a phyllodes tumor of the breast. 61
7553578 1995
186
Is i(1)(q10) a chromosome marker in phyllodes tumor of the breast? 61
7553592 1995
187
Clinicopathologic study of phyllodes tumor of the breast. 61
7613256 1995
188
A Malignant Phyllodes Tumor of the Breast in a 6-Year Old Girl. 61
11091535 1995
189
Phyllodes tumor of the breast. 61
7839306 1995
190
Flow Cytometric Analysis to Assess the Malignant Potential of Phyllodes Tumor. 61
11091522 1994
191
Phyllodes tumor of the breast containing the intracytoplasmic inclusion bodies identical with infantile digital fibromatosis. 61
8172324 1994
192
Phyllodes tumor of the breast. An immunohistochemical study of 28 cases with special attention to the role of myofibroblasts. 61
7991467 1994
193
Patterns of p53 expression in phyllodes tumors of the breast--an immunohistochemical study. 61
8305139 1993
194
Clonal analysis of fibroadenoma and phyllodes tumor of the breast. 61
8395336 1993
195
Phyllodes tumor of the breast: problems of differential diagnosis and therapeutic approach from an analysis of 17 cases. 61
8382173 1993
196
99mTc-HMDP accumulation in a phyllodes tumor of the breast, a case report. 61
8384869 1993
197
Phyllodes tumor of the breast: a multicenter series of 59 cases. Coordinating Center and Writing Committee of FONCAM (National Task Force for Breast Cancer), Italy. 61
1335886 1992
198
[Diagnosis, prognosis and therapy of phyllodes tumor of the breast]. 61
1329905 1992
199
[Phyllodes tumor of the breast]. 61
1331870 1992
200
Apocrine metaplasia in phyllodes tumor of the breast. 61
2171287 1990
201
Apocrine and bony metaplasia in a borderline phyllodes tumor of the breast. 61
2171288 1990
202
Phyllodes tumor of the breast: a clinicopathologic study of 34 cases. 61
2166186 1990
203
Small sized phyllodes tumor of the breast. 61
2161352 1990
204
[A case of giant phyllodes tumor with special reference to its process of enlargement]. 61
1966666 1990
205
[Phyllodes tumor of the breast (cystosarcoma phyllodes) (apropos 3 cases)]. 61
1963818 1990
206
[Phyllodes tumor of the breast]. 61
2552357 1989
207
[Phyllodes tumor of the breast with stromal metaplasia]. 61
2834111 1988
208
Multinucleated giant cells in malignant phyllodes tumor of the breast. 61
3179069 1988
209
[Phyllodes tumor of the breast in an 11-year-old child]. 61
2849086 1988
210
Intraductal carcinoma within a phyllodes tumor of the breast: a case report. 61
3010519 1986
211
[Primary retroperitoneal tumor (Dominici's mesenchymoma) associated with leiomyoma of the sigmoid, a phyllodes tumor of the breast and uterine myomatosis]. 61
6093207 1984
212
[Anatomical and clinical deliberations on the phyllodes tumor of the breast]. 61
184625 1976
213
[Phyllodes tumor of the breast. Anatomo-clinical considerations and case reports]. 61
4320392 1969
214
[Phyllodes tumor of the breast]. 61
14459798 1962
215
[Malignant form of Mueller's phyllodes tumor of the breast]. 61
13932894 1961
216
[Clinical aspects of phyllodes tumor of the breast]. 61
13623443 1958
217
[Case of phyllodes tumor of the breast]. 61
13453797 1957
218
[A case of phyllodes tumor of the breast in a 15-year-old girl]. 61
13298041 1955

Variations for Breast Malignant Phyllodes Tumor

Expression for Breast Malignant Phyllodes Tumor

Search GEO for disease gene expression data for Breast Malignant Phyllodes Tumor.

Pathways for Breast Malignant Phyllodes Tumor

Pathways related to Breast Malignant Phyllodes Tumor according to GeneCards Suite gene sharing:

(showing 18, show less)
# Super pathways Score Top Affiliating Genes
1 12.54 TP53 KIT ERBB2 EGFR
2 12.53 TP53 KIT ESR1 ERBB2 EGFR
3
Show member pathways
12.49 TP53 KIT ERBB2 EGFR
4
Show member pathways
12.43 TP53 ESR1 ERBB2 EGFR
5
Show member pathways
12.1 TP53 PGR KIT ESR1 ERBB2 EGFR
6 11.93 TP53 ESR1 EGFR
7 11.93 TP53 ESR1 ERBB2 EGFR
8 11.9 KIT ERBB2 EGFR
9
Show member pathways
11.79 TP53 ERBB2 EGFR
10 11.76 TP53 MED12 ESR1
11 11.74 MME KIT CD34
12 11.65 MME KIT CD34
13
Show member pathways
11.59 PGR ESR1 ERBB2 EGFR
14 11.5 MME KIT CD34
15 11.47 TP53 ERBB2 EGFR
16
Show member pathways
11.43 KIT ESR1 ERBB2 EGFR
17 11.27 MME KIT CD34
18 10.76 TP53 KIT ERBB2 EGFR

GO Terms for Breast Malignant Phyllodes Tumor

Cellular components related to Breast Malignant Phyllodes Tumor according to GeneCards Suite gene sharing:

(showing 1, show less)
# Name GO ID Score Top Affiliating Genes
1 basal plasma membrane GO:0009925 8.8 ERBB2 EGFR CD34

Biological processes related to Breast Malignant Phyllodes Tumor according to GeneCards Suite gene sharing:

(showing 16, show less)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.86 TP53 KIT ERBB2 CD34
2 peptidyl-tyrosine phosphorylation GO:0018108 9.72 KIT ERBB2 EGFR
3 transmembrane receptor protein tyrosine kinase signaling pathway GO:0007169 9.71 KIT ERBB2 EGFR
4 negative regulation of gene expression GO:0010629 9.67 TP53 PGR ESR1 CD34
5 wound healing GO:0042060 9.63 TP53 ERBB2 EGFR
6 replicative senescence GO:0090399 9.52 TP53 MME
7 positive regulation of phospholipase C activity GO:0010863 9.51 KIT ESR1
8 tongue development GO:0043586 9.49 KIT EGFR
9 positive regulation of RNA polymerase II transcriptional preinitiation complex assembly GO:0045899 9.48 TP53 ESR1
10 positive regulation of production of miRNAs involved in gene silencing by miRNA GO:1903800 9.43 TP53 EGFR
11 negative regulation of production of miRNAs involved in gene silencing by miRNA GO:1903799 9.4 TP53 ESR1
12 positive regulation of MAP kinase activity GO:0043406 9.33 KIT ERBB2 EGFR
13 paracrine signaling GO:0038001 9.32 PGR CD34
14 negative regulation of ERBB signaling pathway GO:1901185 9.26 ERBB2 EGFR
15 positive regulation of protein kinase B signaling GO:0051897 9.26 KIT ESR1 ERBB2 EGFR
16 regulation of transcription by RNA polymerase II GO:0006357 9.1 TP53 MED12 KIT ESR1 ERBB2 EGFR

Molecular functions related to Breast Malignant Phyllodes Tumor according to GeneCards Suite gene sharing:

(showing 7, show less)
# Name GO ID Score Top Affiliating Genes
1 chromatin binding GO:0003682 9.71 TP53 MED12 ESR1 EGFR
2 enzyme binding GO:0019899 9.62 TP53 PGR ESR1 EGFR
3 transcription factor binding GO:0008134 9.56 TP53 MED12 ESR1 CD34
4 protein tyrosine kinase activity GO:0004713 9.54 KIT ERBB2 EGFR
5 protein phosphatase binding GO:0019903 9.33 TP53 ERBB2 EGFR
6 nitric-oxide synthase regulator activity GO:0030235 8.96 ESR1 EGFR
7 transmembrane receptor protein tyrosine kinase activity GO:0004714 8.8 KIT ERBB2 EGFR

Sources for Breast Malignant Phyllodes Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....